Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas

Histopathology

Volumn 43, Issue 5, 2003, Pages 453-461

  Gulmann, C ^a   Counihan, I ^a   Grace, A ^a   Patchett, S ^a   Leen, E ^b   Leader, M ^a   Kay, E ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b Royal College of Surgeons in Ireland   (Ireland)

Author keywords

Cytokeratin 7 20; Gastric adenocarcinoma; MUC; Oesophageal adenocarcinoma; Tissue microarray

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; GLYCOPROTEIN; MUCIN; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CARDIA CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; MALE; MIDDLE AGED; MUCINS; NEOPLASM STAGING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0344413061     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01724.x     Document Type: Article

References (30)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998: 83; 2049-2053.
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991: 265; 1287-1289.
3. Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res. 2000: 155; 1-14.
4. Stein HJ, Feith M, Siewert JR. Cancer of the esophagogastric junction. Surg. Oncol. 2000: 9; 35-41.
5. Taniere P, Martel-Planche G, Maurici D et al. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am. J. Pathol. 2001: 158; 33-40.
6. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002: 40; 403-439.
7. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 2000: 13; 962-972.
8. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Gramlich TL. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 2001: 38; 307-311.
9. Taniere P, Borghi-Scoazec G, Saurin JC et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am. J. Surg. Pathol. 2002: 26: 1213-1221.
10. Carrato C, Balague C, de Bolos C et al. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology 1994: 107; 160-172.
11. Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 2000: 47; 753-761.
12. Guillem P, Billeret V, Buisine MP et al. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int. J. Cancer 2000: 88; 856-861.
13. Pinto-De-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 2002: 440; 304-310.
14. Gurbuz Y, Kahlke V, Kloppel G. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch. 2002: 440; 505-511.
15. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1. MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 2001: 92; 1427-1434.
16. Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J. Pathol 2000: 190; 437-443.
17. Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. APMIS 1965: 64; 31-49.
18. Moch H, Kononen T, Kallioniemi OP, Sauter G. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv. Anat. Pathol 2001: 8; 14-20.
19. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 1998: 4; 844-847.
20. van Dekken H, Alers JC, Riegman PH, Rosenberg C, Tilanus HW, Vissers K. Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am. J. Pathol. 2001: 158; 1961-1967.
21. Clark GW, Smyrk TC, Burdiles P et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch. Surg. 1994: 129; 609-614.
22. Hackelsberger A, Gunther T, Schultze V et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998: 43; 17-21.
23. Goldblum JR. Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both. Dig. Dis 2000: 18; 14-19.
24. Kakar S, Burgart LJ. Adenocarcinoma of the esophagus and gastric cardia: two diseases or one? Pathol. Case Rev. 2002: 7; 43-47.
25. Baldus SE, Zirbes TK, Engel S et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int. J. Cancer 1998: 79; 133-138.
26. Reis CA, David L, Seixas M, Burchell J, Sobrinho-Simoes M. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int. J. Cancer 1998: 79; 402-410.
27. Kende AI, Carr NJ, Sobin LH. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology 2003: 42; 137-140.
28. Sauter G, Mirlacher M. Tissue microarrays for predictive molecular pathology. J. Clin. Pathol 2002: 55; 575-576.
29. Ormsby AH, Goldblum JR, Rice TW et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum. Pathol. 1999: 30; 288-294.
30. Glickman JN, Wang H, Das KM et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am. J. Surg. Pathol. 2001: 25; 87-94.